IBD | CHOP Research Institute
 

IBD

Inflammatory Bowel Disease (IBD) can sometimes add stress to your life and that may affect your physical symptoms of pain and stool habits. In this study, we want to know if practicing mindfulness via an online Mindfulness-based stress reduction (MBSR) course taught by a trained teacher can help with your IBD.

The purpose of this research study is to collect information over time in juvenile SpA and back pain patients.

The Hamilton Lab studies epithelial cells in the intestine and colon and the roles they play in maintaining human health.

The Center for Applied Genomics (CAG) develops new and better ways to diagnose and treat children with genetic disorders, including attention-deficit/hyperactivity disorder, asthm

Published on
Mar 12, 2021
Our March featured faculty member, Kathryn Hamilton, PhD, studies gastrointestinal epithelial stem cells.

Generating new insights from multidisciplinary translational research to provide personalized therapy worldwide for more children with inflammatory bowel disease.

Improving the safety, quality, and health outcomes of pediatric care through clinical research. PeRC’s mission is to provide the expertise and infrastructure needed to support research within the primary care setting.

Dr. Kennedy's current research focuses on epilepsy genetics and epilepsy surgery, including stereo-EEG, hemispherotomy, corpus callosotomy, and vagal nerve stimulation.

E-mail:
kennedybc [at] chop.edu

Dr. Kelsen’s research focus is on the genetic, immunologic, and microbiomic causes of very early onset inflammatory bowel disease. Through a multidisciplinary team approach, Dr. Kelsen and her colleagues perform genetic sequencing to identify causative genetic variants in children with VEO-IBD, study the function of these variants, and use this information to improve the clinical outcomes for these children.

E-mail:
kelsen [at] chop.edu

Dr. Hakonarson is director of the Center for Applied Genomics and professor of Pediatrics at the Perelman School of Medicine, University of Pennsylvania. He leads a $40 million commitment from Children’s Hospital of Philadelphia to genomically characterize approximately 100,000 children, an initiative that has gained nationwide attention in the Wall Street Journal, New York Times, Time Magazine, Nature, and Science.

E-mail:
hakonarson [at] chop.edu